However, other in vitro studies of TGF-β-induced EMT have identified miR-155, by RhoA targeting [60], and especially the miR-200 family in tumor metastasis, by targeting E-cadherin transcriptional repressors ZEB1/ZEB2 [25], [26], [28], as EMT-promoting miRNAs. The gene discussed is ZEB1; the disease is neoplasm.